FDA Inspection 1045598 — Tomita Pharmaceutical Co., Ltd.

Tomita Pharmaceutical Co., Ltd. — FEI 3002808375

The FDA completed an inspection of Tomita Pharmaceutical Co., Ltd. on March 9, 2018 in Naruto. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 9, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Naruto (Japan)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
125121 CFR 211.42(c)(1)Incoming material area
188521 CFR 211.165(b)Microbiological testing
356521 CFR 211.58Buildings not maintained in good state of repair